Target intelligence / Profile preview

ADP-ribosylation factor-like 2 binding protein pseudogene

Molecular classification
Pseudogene
01

Overview

The ADP-ribosylation factor-like 2 binding protein pseudogene, identified by the Ensembl gene ID ENSG00000259608, is a sequence in the human genome that closely resembles the functional gene encoding the ADP-ribosylation factor-like 2 binding protein, but lacks the ability to produce a functional protein product. Pseudogenes typically arise by gene duplication or retrotransposition, and accumulate disabling mutations such as premature stops or frameshifts that render them noncoding. While a small number of pseudogenes can be transcribed or produce regulatory RNA, this is uncommon and no specific function or clinical significance is documented for ENSG00000259608. Pseudogenes like this one are not considered therapeutic targets, receptors, or biomarkers, and are primarily relevant in genomics as nonfunctional evolutionary remnants or possible sources of regulatory sequences.

02

Biological functions

Other (pseudogenes may occasionally have regulatory RNA functions but this is rare and not proven for this specific one)
03

Disease associations

Other (Most pseudogenes have no established direct disease relevance, although a minor subset may possess regulatory roles in gene networks; none are documented for this specific entry)
04

Safety considerations

pseudogenes generally pose no direct therapeutic risks; however, their sequence similarity to functional genes can complicate genetic assays such as PCR

Beyond the preview

Go deeper on ADP-ribosylation factor-like 2 binding protein pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosylation factor-like 2 binding protein pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call